AU4706199A - Compositions and methods for inducing apoptosis in e6-expressing cells - Google Patents

Compositions and methods for inducing apoptosis in e6-expressing cells

Info

Publication number
AU4706199A
AU4706199A AU47061/99A AU4706199A AU4706199A AU 4706199 A AU4706199 A AU 4706199A AU 47061/99 A AU47061/99 A AU 47061/99A AU 4706199 A AU4706199 A AU 4706199A AU 4706199 A AU4706199 A AU 4706199A
Authority
AU
Australia
Prior art keywords
compositions
methods
expressing cells
inducing apoptosis
apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47061/99A
Inventor
Wafik S. El-Deiry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of AU4706199A publication Critical patent/AU4706199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU47061/99A 1998-06-24 1999-06-23 Compositions and methods for inducing apoptosis in e6-expressing cells Abandoned AU4706199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9052698P 1998-06-24 1998-06-24
US60090526 1998-06-24
PCT/US1999/014057 WO1999066946A1 (en) 1998-06-24 1999-06-23 Compositions and methods for inducing apoptosis in e6-expressing cells

Publications (1)

Publication Number Publication Date
AU4706199A true AU4706199A (en) 2000-01-10

Family

ID=22223175

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47061/99A Abandoned AU4706199A (en) 1998-06-24 1999-06-23 Compositions and methods for inducing apoptosis in e6-expressing cells

Country Status (2)

Country Link
AU (1) AU4706199A (en)
WO (1) WO1999066946A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744455B1 (en) 1996-02-02 1998-04-24 Sanofi Sa NOVEL NUCLEIC ACID SEQUENCES OF THE FAMILY OF TUMOR SUPPRESSOR FACTORS, CORRESPONDING EXPRESSION PRODUCTS AND THEIR APPLICATIONS
GB0128898D0 (en) 2001-12-03 2002-01-23 Biotech Res Ventures Pte Ltd Materials and methods relating to the stabilization and activation of a tumour suppressor protein
WO2004108142A2 (en) * 2003-06-06 2004-12-16 The University Of Manchester Inhibitors of tip-1 for treatment tissue damage
ITMI20042227A1 (en) * 2004-11-19 2005-02-19 Ist Fisioterap Ospitalroma PEPTIDE ABLE TO BREAK THE COMPLEX M-P53-P63, M-P53-P73 AND M-P53-RELATIVE ISO-FORMS PROTEINS FORMED IN TUMOR CELLS AND RELATIVE USES IN THE PHARMACOLOGICAL FIELD
GB0701818D0 (en) * 2007-01-31 2007-03-14 Univ Manchester Prognostic marker for cancer
KR101866152B1 (en) 2008-12-04 2018-06-08 큐알엔에이, 인크. Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene

Also Published As

Publication number Publication date
WO1999066946A1 (en) 1999-12-29

Similar Documents

Publication Publication Date Title
AU3731400A (en) Methods and compositions useful in inhibiting apoptosis
AU3116800A (en) Compositions and methods for altering cell migration
AU2846699A (en) Improvements in or relating to enclosures
AU6580998A (en) Screening methods in eucaryotic cells
AU5898599A (en) Methods and compositions for genomic modification
AU4402899A (en) Absorbent structure in an absorbent article
AU3671099A (en) Methods and compositions pertaining to pd-loops
AU2349399A (en) R-lansoprazole compositions and methods
AU5565099A (en) Pharmaceutical compositions and methods for use
AU4215399A (en) Dermatological compositions and methods
AU1889899A (en) Enclosed cell and sealer
EP1056457A4 (en) S-lansoprazole compositions and methods
AU7261898A (en) Methods for viral inactivation and compositions for use in same
AU2832399A (en) B cell inhibitors
AU9301998A (en) Composition and methods using galectin-1
AUPP227898A0 (en) Improvements in ultrasound techniques
EP1073333A4 (en) S-rabeprazole compositions and methods
AUPP135598A0 (en) Improvements in or relating to comminution devices
AU749278C (en) Composition for use in dementia
AU4706199A (en) Compositions and methods for inducing apoptosis in e6-expressing cells
AU4859399A (en) Compositions and methods for treating papillomavirus-infected cells
AU2346800A (en) Compositions and methods using cell fusion
AU6736598A (en) Methods for selecting cells and their uses
GB0318112D0 (en) ›-Secretase enzyme compositions and methods
AUPO982097A0 (en) Methods and compositions for use therein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase